Accordingly, SCD-1 expression is enhanced in breast and prostate cancer tissues in situ compared to normal tissue [26–31] and SCD-1 expression was associated with shorter survival times in breast cancer patients [27]. The gene discussed is SCD; the disease is prostate carcinoma.